Pietro Pozzi

The antitumor histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits antiinflammatory properties via suppression of cytokines

Flavio Leoni, Andrea Zaliani, Giorgio Bertolini et al. · Proceedings of the National Academy of Sciences · 2002 · 500 citations · Full text

Chemoprevention Strategy, Immunology, Cell Death +18

The Histone Deacetylase Inhibitor ITF2357 Reduces Production of Pro-Inflammatory Cytokines In Vitro and Systemic Inflammation In Vivo

Flavio Leoni, Gianluca Fossati, Eli C. Lewis et al. · Molecular Medicine · 2005 · 324 citations · Full text

Six different cytokines that share GP130 as a receptor subunit, induce serum amyloid A and potentiate the induction of interleukin-6 and the activation of the hypothalamus-pituitary-adrenal axis by interleukin-1

Fabio Benigni, Giamila Fantuzzi, Silvano Sacco et al. · Blood · 1996 · 114 citations

The histone deacetylase inhibitor ITF2357 has anti-leukemic activity in vitro and in vivo and inhibits IL-6 and VEGF production by stromal cells

Josée Golay, Lucia Cuppini, F. Leoni et al. · Leukemia · 2007 · 106 citations

Histone Modifications, Chromatin, Tumor Biology +9

Specific Inhibition of Histone Deacetylase 8 Reduces Gene Expression and Production of Proinflammatory Cytokines in Vitro and in Vivo

Suzhao Li, Gianluca Fossati, Carlo Marchetti et al. · Journal of Biological Chemistry · 2014 · 62 citations · Full text

Histone Modifications, Chromatin, Inflammation +13